Geopolitics Alpha

8-K - Arcturus Therapeutics Holdings Inc. (0001768224) (Filer)

Published . Updated .

Key takeaways

  • 8-K - Arcturus Therapeutics Holdings filed an 8-K with the SEC on Nov 16 (a notice of a material company event).
  • Exposed: ARCT
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHA8-K - Arcturus TherapeuticsHoldings Inc. (0001768224) (Filer)ARCTGEOPOLITICS ALPHA

8-K - Arcturus Therapeutics Holdings filed an 8-K with the SEC on Nov 16 (a notice of a material company event).

Directly affected

  • ARCT Arcturus Therapeutics Holdings-41.6% 30d

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Arcturus Therapeutics Holdings belongs to, so it often moves with news about it.

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and is a peer of Arcturus Therapeutics Holdings in pharmaceutical preparations; rivals often move on the same news.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson is a peer of Arcturus Therapeutics Holdings in pharmaceutical preparations; rivals often move on the same news.

  • ABBV AbbVie+12.0% 30d

    AbbVie is a peer of Arcturus Therapeutics Holdings in pharmaceutical preparations; rivals often move on the same news.

  • MRK Merck+3.5% 30d

    Merck is a peer of Arcturus Therapeutics Holdings in pharmaceutical preparations; rivals often move on the same news.

  • ABT Abbott Laboratories+10.0% 30d

    Abbott Laboratories is a peer of Arcturus Therapeutics Holdings in pharmaceutical preparations; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
ARCT+13.91%+11.81%baseafter closeafter closeafter closeafter close
XLV-0.28%+0.04%baseafter closeafter closeafter closeafter close
LLY-2.25%-0.49%baseafter closeafter closeafter closeafter close
JNJ-1.35%-1.97%baseafter closeafter closeafter closeafter close
ABBV-0.57%-0.04%baseafter closeafter closeafter closeafter close
MRK+0.65%-0.38%baseafter closeafter closeafter closeafter close
ABT+1.85%+0.80%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-11-16 AccNo: 0001193805-26-001485 Size: 211 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exh…

Source: sec-edgar

How far Arcturus Therapeutics Holdings (ARCT) has moved since 16 Nov 2026

CompanyWhenMoveStatus
ABBVthree days earlier-0.04%final price
ABBVfive days earlier-0.57%final price
ABTthree days earlier+0.80%final price
ABTfive days earlier+1.85%final price
Arcturus Therapeutics Holdings (ARCT)three days earlier+11.81%final price
Arcturus Therapeutics Holdings (ARCT)five days earlier+13.91%final price
JNJthree days earlier-1.97%final price
JNJfive days earlier-1.35%final price
LLYthree days earlier-0.49%final price
LLYfive days earlier-2.25%final price
MRKthree days earlier-0.38%final price
MRKfive days earlier+0.65%final price
XLVthree days earlier+0.04%final price
XLVfive days earlier-0.28%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Arcturus Therapeutics Holdings (ARCT)

Companies carried with this story

  • ARCT Arcturus Therapeutics Holdings

    Arcturus Therapeutics Holdings (ARCT) is linked, with no stored direction, high confidence in the 16 Nov 2026 story “8-K - Arcturus Therapeutics Holdings Inc. (0001768224) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> ARCT

Arcturus Therapeutics Holdings (ARCT)

On 16 Nov 2026, “8-K - Arcturus Therapeutics Holdings Inc. (0001768224) (Filer)” is the story that connects Arcturus Therapeutics Holdings (ARCT) to this story.

What ties Arcturus Therapeutics Holdings (ARCT) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> ARCT

The price range for Arcturus Therapeutics Holdings (ARCT), and the dates in the story

ARCT traded between 8.42 and 15.15 across 16 sessions. The latest close on file is 8.44.

What the saved facts support for Arcturus Therapeutics Holdings (ARCT)

14 out of 100

“8-K - Arcturus Therapeutics Holdings Inc. (0001768224) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.